As shifting rain patterns and rising heat challenge farmers, Cornell’s Prof. Margaret Smith underscores that sustaining ...

Get the latest insights from OraSure Technologies' Q3 2025 earnings call—portfolio expansion, BioMedomics acquisition, growth strategy, and financial outlook.

Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.22 per share a year ago. These ...

Adma Biologics (ADMA) came out with quarterly earnings of $0.16 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.15 per share a year ago. These figures are ...

Genetically engineered breeders that lay only female chicks would eliminate the culling of day-old male chicks.

New data reveals differences in gene activity in the brains of men and women. They start in the womb and evolved millions of ...

Myriad Genetics (MYGN) stock is downgraded from a "Buy" to "Hold" due to flat Q3 2025 earnings and limited near-term revenue ...

The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both ...

Mr. Brady became the latest celebrity to try to preserve a pet’s genetics, a move that animal rights groups have criticized.

Envu has made several personnel changes to strengthen its U.S marketing team, while Star Roses has restructured its woody ...

Developing high-yielding, nutritious and climate-resilient crops is vital to safeguard the future of global food production.

Tom Brady has revealed that his dog is a clone of a dead former pet of his. The National Football League icon and Birmingham City co-owner announced the news in a statement released via Colossal ...